论文部分内容阅读
目的观察血必净联合抗生素在重度烧伤治疗中的临床疗效。方法采用回顾性研究,将收治的重度烧伤患者60例随机分为治疗组和对照组,分别采用血必净联合抗生素治疗和常规抗生素治疗,比较两组患者的临床症状及实验室辅助检查指标。结果治疗后两组患者的临床症状及实验室辅助检查结果差异有显著性,治疗组及对照组的有效率分别为93.33%和63.33%,治疗组明显优于对照组,差异有统计学意义(P<0.05)。结论血必净联合抗生素治疗重度烧伤患者,能够明显减轻患者临床症状,抑制过度炎性反应和内毒素释放,临床疗效满意。
Objective To observe the clinical efficacy of Xuebijing combined antibiotics in the treatment of severe burn. Methods A retrospective study of 60 patients with severe burn patients were randomly divided into treatment group and control group. The patients were treated with Xuebijing combined with antibiotics and routine antibiotics. The clinical symptoms and laboratory tests were compared between the two groups. Results After treatment, the clinical symptoms of the two groups were significantly different from those of laboratory tests. The effective rates in the treatment group and the control group were 93.33% and 63.33%, respectively, which were significantly better in the treatment group than those in the control group (the difference was statistically significant ( P <0.05). Conclusion Xuebijing combined antibiotics in patients with severe burn can significantly reduce the clinical symptoms and inhibit excessive inflammatory response and endotoxin release, the clinical efficacy is satisfactory.